“…[1][2][3][4] The spectrum of suramin applications now includes the clinical treatment of angiogenesis, carcinomas of the kidney and prostate gland, breast cancer, inhibition of growth factor/receptor interactions, inhibition of human a-thrombin, protein-tyrosine phosphatases, G proteins, merozoite surface protein-1, and acidic and basic fibroblast growth factors. [5][6][7][8][9][10][11][12][13][14] Suramin prevents the development of muscle necrosis induced by some snake venoms, since it inhibits the myotoxic and in vitro neuromuscular blocking activities of Lys49 phospholipases A 2 from Bothrops species. 15,16 Phospholipases A 2 (PLA 2 s: EC 3.1.…”